Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1267/ahc.10003 http://scihub22266oqcxt.onion/10.1267/ahc.10003 20514291/?report=reader!2875858!20514291     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Histochem+Cytochem 2010 ; 43 (2): 45-50 Nephropedia Template TP {{tp|p=20514291|t=2010. Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors |pdf=|usr=}}{{20514291}} gab.com Text Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors JO: Acta Histochem Cytochem http://www.kidney.de/pget.php?&tw=1&pmid=20514291 #FOAvip Functional chemokine receptors are expressed in many malignant tumors. These receptors promote tumor growth and metastasis in response to endogenous chemokines. We analyzed the expression of CXCR4, CCR6 and CCR7 in fibrohistiocytic tumors, including dermatofibrosarcoma protuberance (DFSP), malignant fibrous histiocytoma (MFH), dermatofibroma (DF) using immunohistochemistry. We also investigated the relationship between CXCR4 and CD34, the latter of which is an immunohistochemical marker for DFSP. We observed a higher expression of CXCR4 in DFSP and MFH as compared with DF. Interestingly, a significantly higher expression of CXCR4 was detected in relapsed DFSP than in non-relapsed DFSP, but no significant differences were detected between non-relapsed DFSP and DFSP with CD34 immunostaining. Moreover, MFH had strong immunoreactivity for CXCR4, CCR6 and CCR7. These findings suggest that the assessment of CXCR4 immunoreactivity in fibrohistiocytic tumors is a useful tool for predicting tumor aggressiveness. Twit Text FOAVip Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors ????Acta Histochem Cytochem http://www.kidney.de/pget.php?&tw=1&pmid=20514291 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=20514291 #FOAvip English Wikipedia <ref>{{Cite pmid|20514291}}</ref> Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors #MMPMID20514291 Toyozawa S; Yamamoto Y; Ishida Y; Kondo T; Nakamura Y; Furukawa F Acta Histochem Cytochem 2010[May]; 43 (2): 45-50 PMID20514291show ga Functional chemokine receptors are expressed in many malignant tumors. These receptors promote tumor growth and metastasis in response to endogenous chemokines. We analyzed the expression of CXCR4, CCR6 and CCR7 in fibrohistiocytic tumors, including dermatofibrosarcoma protuberance (DFSP), malignant fibrous histiocytoma (MFH), dermatofibroma (DF) using immunohistochemistry. We also investigated the relationship between CXCR4 and CD34, the latter of which is an immunohistochemical marker for DFSP. We observed a higher expression of CXCR4 in DFSP and MFH as compared with DF. Interestingly, a significantly higher expression of CXCR4 was detected in relapsed DFSP than in non-relapsed DFSP, but no significant differences were detected between non-relapsed DFSP and DFSP with CD34 immunostaining. Moreover, MFH had strong immunoreactivity for CXCR4, CCR6 and CCR7. These findings suggest that the assessment of CXCR4 immunoreactivity in fibrohistiocytic tumors is a useful tool for predicting tumor aggressiveness. äImmunohistochemical analysis of CXCR4 expression in fibrohistiocytic t(epmc).pdf DeepDyve Pubget Overpricing